Confirmatory biomarker diagnostic studies are not needed when transitioning from NAFLD to MASLD.

Ratziu V, Boursier J; AFEF Group for the Study of Liver Fibrosis. J Hepatol. 2023 Aug 3:S0168-8278(23)04996-6. doi: 10.1016/j.jhep.2023.07.017.